|
1
|
Kim EH and Misek DE: Glycoproteomics-based
identification of cancer biomarkers. Int J Proteomics.
2011:6019372011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Liu Q, Tan SY and Jiang YH:
Association between carcinoembryonic antigen, carbohydrate antigen
19–9 and body mass index in colorectal cancer patients. Mol Clin
Oncol. 1:879–886. 2013.
|
|
3
|
Yoon YS, Keum N, Zhang X, Cho E and
Giovannucci EL: Circulating levels of IGF-1, IGFBP-3, and
IGF-1/IGFBP-3 molar ratio and colorectal adenomas: A meta-analysis.
Cancer Epidemiol. 39:1026–1035. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Woo HD, Kim K and Kim J: Association
between preoperative C-reactive protein level and colorectal cancer
survival: A meta-analysis. Cancer Causes Control. 26:1661–1670.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taniguchi N and Kizuka Y: Glycans and
cancer: Role of N-glycans in cancer biomarker, progression and
metastasis, and therapeutics. Adv Cancer Res. 126:11–51. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meany DL and Chan DW: Aberrant
glycosylation associated with enzymes as cancer biomarkers. Clin
Proteomics. 8:72011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brooks SA: The involvement of Helix
pomatia lectin (HPA) binding N-acetylgalactosamine glycans in
cancer progression. Histol Histopathol. 15:143–158. 2000.PubMed/NCBI
|
|
8
|
Hollingsworth MA and Swanson BJ: Mucins in
cancer: Protection and control of the cell surface. Nat Rev Cancer.
4:45–60. 2004. View
Article : Google Scholar
|
|
9
|
Haugstad KE, Gerken TA, Stokke BT, Dam TK,
Brewer CF and Sletmoen M: Enhanced self-association of mucins
possessing the T and Tn carbohydrate cancer antigens at the
single-molecule level. Biomacromolecules. 13:1400–1409. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Conze T, Carvalho AS, Landegren U, Almeida
R, Reis CA, David L and Söderberg O: MUC2 mucin is a major carrier
of the cancer-associated sialyl-Tn antigen in intestinal metaplasia
and gastric carcinomas. Glycobiology. 20:199–206. 2010. View Article : Google Scholar
|
|
11
|
Haugstad KE, Stokke BT, Brewer CF, Gerken
TA and Sletmoen M: Single molecule study of heterotypic
interactions between mucins possessing the Tn cancer antigen.
Glycobiology. 25:524–534. 2015. View Article : Google Scholar :
|
|
12
|
Julien S, Videira PA and Delannoy P:
Sialyl-tn in cancer: (how) did we miss the target? Biomolecules.
2:435–466. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sousa BL, Silva Filho JC, Kumar P, Pereira
RI, Łyskowski A, Rocha BA, Delatorre P, Bezerra GA, Nagano CS,
Gruber K, et al: High-resolution structure of a new Tn
antigen-binding lectin from Vatairea macrocarpa and a comparative
analysis of Tn-binding legume lectins. Int J Biochem Cell Biol.
59:103–110. 2015. View Article : Google Scholar
|
|
14
|
Mazal D, Lo-Man R, Bay S, Pritsch O,
Dériaud E, Ganneau C, Medeiros A, Ubillos L, Obal G, Berois N, et
al: Monoclonal antibodies toward different Tn-amino acid backbones
display distinct recognition patterns on human cancer cells.
Implications for effective immuno-targeting of cancer. Cancer
Immunol Immunother. 62:1107–1122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barrow H, Tam B, Duckworth CA, Rhodes JM
and Yu LG: Suppression of core 1 Gal-transferase is associated with
reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3
glycans in human colon cancer cells. PLoS One. 8:e597922013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Holmberg LA, Oparin DV, Gooley T, Lilleby
K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM and
Sandmaier BM: Clinical outcome of breast and ovarian cancer
patients treated with high-dose chemotherapy, autologous stem cell
rescue and THERATOPE STn-KLH cancer vaccine. Bone Marrow
Transplant. 25:1233–1241. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsumoto Y, Zhang Q, Akita K, Nakada H,
Hamamura K, Tsuchida A, Okajima T and Furukawa K, Urano T and
Furukawa K: Trimeric Tn antigen on syndecan 1 produced by
ppGalNAc-T13 enhances cancer metastasis via a complex formation
with integrin α5β1 and matrix metalloproteinase 9. J Biol Chem.
288:24264–24276. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Song K, Herzog BH, Fu J, Sheng M,
Bergstrom K, McDaniel JM, Kondo Y, McGee S, Cai X, Li P, et al:
Loss of core 1-derived O-glycans decreases breast cancer
development in mice. J Biol Chem. 290:20159–20166. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hofmann BT, Schlüter L, Lange P,
Mercanoglu B, Ewald F, Fölster A, Picksak AS, Harder S, El Gammal
AT, Grupp K, et al: COSMC knockdown mediated aberrant
O-glycosylation promotes oncogenic properties in pancreatic cancer.
Mol Cancer. 14:1092015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Loureiro LR, Carrascal MA, Barbas A,
Ramalho JS, Novo C, Delannoy P and Videira PA: Challenges in
antibody development against Tn and sialyl-Tn antigens.
Biomolecules. 5:1783–1809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tavares C, de Oliveira JT, Lopes C,
Carvalheira J, Matos AJ, Rutteman G, Reis CA and Gärtner F: Mucin 6
and Tn antigen expression in canine mammary tumours: Correlation
with pathological features. J Comp Pathol. 147:410–418. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lescar J, Sanchez JF, Audfray A, Coll JL,
Breton C, Mitchell EP and Imberty A: Structural basis for
recognition of breast and colon cancer epitopes Tn antigen and
Forssman disaccharide by Helix pomatia lectin. Glycobiology.
17:1077–1083. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zamri N, Masuda N, Oura F, Yajima Y,
Nakada H and Fujita-Yamaguchi Y: Effects of two monoclonal
antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like
growth factor-I receptor, on the growth of colon cancer cells.
Biosci Trends. 6:303–312. 2012.
|
|
24
|
Ju T, Aryal RP, Kudelka MR, Wang Y and
Cummings RD: The Cosmc connection to the Tn antigen in cancer.
Cancer biomarkers: Section. Dis Markers. 14:63–81. 2014.
|
|
25
|
Takamiya R, Ohtsubo K, Takamatsu S,
Taniguchi N and Angata T: The interaction between Siglec-15 and
tumor-associated sialyl-Tn antigen enhances TGF-β secretion from
monocytes/macrophages through the DAP12-Syk pathway. Glycobiology.
23:178–187. 2013. View Article : Google Scholar
|
|
26
|
Berriel E, Hill M, Barcia JJ, Ubillos L,
Gonzalez M, Detjen G, Rondan M, Navarrete H and Osinaga E: Simple
mucin-type cancer associated antigens are pre-cancerous biomarkers
during 1,2-dimethylhydrazine-induced rat colon carcinogenesis.
Oncol Rep. 14:219–227. 2005.PubMed/NCBI
|
|
27
|
Troup S, Njue C, Kliewer EV, Parisien M,
Roskelley C, Chakravarti S, Roughley PJ, Murphy LC and Watson PH:
Reduced expression of the small leucine-rich proteoglycans,
lumican, and decorin is associated with poor outcome in
node-negative invasive breast cancer. Clin Cancer Res. 9:207–214.
2003.PubMed/NCBI
|
|
28
|
Oura F, Yajima Y, Nakata M, Taniue K,
Akiyama T, Nakada H, Yamamoto K and Fujita-Yamaguchi Y:
Susceptibility to proteases of anti-Tn-antigen MLS128 binding
glycoproteins expressed in human colon cancer cells. Biosci Trends.
9:49–55. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu X, Du Z, Sun X, Shi C, Zhang H and Hu
T: Aberrant Cosmc genes result in Tn antigen expression in human
colorectal carcinoma cell line HT-29. Int J Clin Exp Pathol.
8:2590–2602. 2015.PubMed/NCBI
|
|
30
|
Lin WH, Huang CJ, Liu MW, Chang HM, Chen
YJ, Tai TY and Chuang LM: Cloning, mapping, and characterization of
the human sorbin and SH3 domain containing 1 (SORBS1) gene: A
protein associated with c-Abl during insulin signaling in the
hepatoma cell line Hep3B. Genomics. 74:12–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Farace C, Oliver JA, Melguizo C, Alvarez
P, Bandiera P, Rama AR, Malaguarnera G, Ortiz R, Madeddu R and
Prados J: Microenvironmental modulation of Decorin and Lumican in
temozolomide-resistant glioblastoma and neuroblastoma cancer
stem-like cells. PLoS One. 10:e01341112015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kioka N, Ueda K and Amachi T: Vinexin,
CAP/ponsin, ArgBP2: A novel adaptor protein family regulating
cytoskeletal organization and signal transduction. Cell Struct
Funct. 27:1–7. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang M, Kimura A and Saltiel AR: Cloning
and characterization of Cbl-associated protein splicing isoforms.
Mol Med. 9:18–25. 2003.PubMed/NCBI
|
|
34
|
Lewis JM, Baskaran R, Taagepera S,
Schwartz MA and Wang JY: Integrin regulation of c-Abl tyrosine
kinase activity and cytoplasmic-nuclear transport. Proc Natl Acad
Sci USA. 93:15174–15179. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang M, Liu J, Cheng A, Deyoung SM, Chen
X, Dold LH and Saltiel AR: CAP interacts with cytoskeletal proteins
and regulates adhesion-mediated ERK activation and motility. EMBO
J. 25:5284–5293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kostic C and Shaw PH: Isolation and
characterization of sixteen novel p53 response genes. Oncogene.
19:3978–3987. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mandai K, Nakanishi H, Satoh A, Takahashi
K, Satoh K, Nishioka H, Mizoguchi A and Takai Y: Ponsin/SH3P12: An
l-afadin- and vinculin-binding protein localized at cell-cell and
cell-matrix adherens junctions. J Cell Biol. 144:1001–1017. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hyakuna N, Muramatsu H, Higa T, Chinen Y,
Wang X and Kojima S: Germline mutation of CBL is associated with
moyamoya disease in a child with juvenile myelomonocytic leukemia
and Noonan syndrome-like disorder. Pediatr Blood Cancer.
62:542–544. 2015. View Article : Google Scholar
|
|
39
|
Michalik L, Desvergne B and Wahli W:
Peroxisome-proliferator-activated receptors and cancers: Complex
stories. Nat Rev Cancer. 4:61–70. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bi X, Pohl NM, Qian Z, Yang GR, Gou Y,
Guzman G, Kajdacsy-Balla A, Iozzo RV and Yang W: Decorin-mediated
inhibition of colorectal cancer growth and migration is associated
with E-cadherin in vitro and in mice. Carcinogenesis. 33:326–330.
2012. View Article : Google Scholar :
|
|
41
|
Campioni M, Ambrogi V, Pompeo E, Citro G,
Castelli M, Spugnini EP, Gatti A, Cardelli P, Lorenzon L, Baldi A,
et al: Identification of genes down-regulated during lung cancer
progression: A cDNA array study. J Exp Clin Cancer Res. 27:382008.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goldoni S, Seidler DG, Heath J, Fassan M,
Baffa R, Thakur ML, Owens RT, McQuillan DJ and Iozzo RV: An
antimetastatic role for decorin in breast cancer. Am J Pathol.
173:844–855. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Reed CC, Waterhouse A, Kirby S, Kay P,
Owens RT, McQuillan DJ and Iozzo RV: Decorin prevents metastatic
spreading of breast cancer. Oncogene. 24:1104–1110. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Liang H, Bai M, Ning T, Wang C, Fan
Q, Wang Y, Fu Z, Wang N, Liu R, et al: miR-135b promotes cancer
progression by targeting transforming growth factor beta receptor
II (TGFBR2) in colorectal cancer. PLoS One. 10:e01301942015.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Biswas S, Guix M, Rinehart C, Dugger TC,
Chytil A, Moses HL, Freeman ML and Arteaga CL: Inhibition of
TGF-beta with neutralizing antibodies prevents radiation-induced
acceleration of metastatic cancer progression. J Clin Invest.
117:1305–1313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
de Miranda NF, van Dinther M, van den
Akker BE, van Wezel T, ten Dijke P and Morreau H: Transforming
growth factor β signaling in colorectal cancer cells with
microsatellite instability despite biallelic mutations in TGFBR2.
Gastroenterology. 148:1427–1437. 2015. View Article : Google Scholar
|
|
47
|
Nischalke HD, Lutz P, Krämer B, Söhne J,
Müller T, Rosendahl J, Fischer J, Berg T, Hittatiya K, Fischer HP,
et al: A common polymorphism in the NCAN gene is associated with
hepatocellular carcinoma in alcoholic liver disease. J Hepatol.
61:1073–1079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kim SY, Choi EJ, Yun JA, Jung ES, Oh ST,
Kim JG, Kang WK and Lee SH: Syndecan-1 expression is associated
with tumor size and EGFR expression in colorectal carcinoma: A
clinicopathological study of 230 cases. Int J Med Sci. 12:92–99.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zaragosi LE, Dadone B, Michiels JF, Marty
M, Pedeutour F, Dani C and Bianchini L: Syndecan-1 regulates
adipogenesis: New insights in dedifferentiated liposarcoma
tumorigenesis. Carcinogenesis. 36:32–40. 2015. View Article : Google Scholar
|
|
50
|
Mundt F, Heidari-Hamedani G, Nilsonne G,
Metintas M, Hjerpe A and Dobra K: Diagnostic and prognostic value
of soluble syndecan-1 in pleural malignancies. BioMed Res Int.
2014:4198532014. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Galvagni F, Orlandini M and Oliviero S:
Role of the AP-1 transcription factor FOSL1 in endothelial cells
adhesion and migration. Cell Adhes Migr. 7:408–411. 2013.
View Article : Google Scholar
|
|
52
|
Zhu W, Li J, Su J, Li J, Li J, Deng B, Shi
Q, Zhou Y and Chen X: FOS-like antigen 1 is highly expressed in
human psoriasis tissues and promotes the growth of HaCaT cells in
vitro. Mol Med Rep. 10:2489–2494. 2014.PubMed/NCBI
|
|
53
|
Liang X, Liu Y, Zeng L, Yu C, Hu Z, Zhou Q
and Yang Z: miR-101 inhibits the G1-to-S phase transition of
cervical cancer cells by targeting Fos. Int J Gynecol Cancer.
24:1165–1172. 2014. View Article : Google Scholar : PubMed/NCBI
|
